Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_assertion type Assertion NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_head.
- NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_assertion description "[The correlations of preS deletion with disease progression were distinct: preS deletion mutations were more commonly found in the hepatocellular carcinoma (HCC) group than in the chronic hepatitis B (CHB) or asymptomatic carrier (ASC) groups, with the frequencies of 38.46% (10/26) in the HCC, 7.14% (2/28) in the CHB, and 4.00% (1/25) in the ASC (P = 0.001) groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_provenance.
- NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_assertion evidence source_evidence_literature NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_provenance.
- NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_assertion SIO_000772 17876546 NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_provenance.
- NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_assertion wasDerivedFrom befree-20140225 NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_provenance.
- NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_assertion wasGeneratedBy ECO_0000203 NP936850.RADEFDrsx3wGWF-reAvOfLlQqdLtlWkxgcZgUIsFq4fDQ130_provenance.